These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5509848)

  • 21. Biguanides enhance glucose utilization and insulin action in peripheral tissues: an old finding from the sixties of the last century.
    Schatz H
    Horm Metab Res; 2006 Oct; 38(10):690. PubMed ID: 17075781
    [No Abstract]   [Full Text] [Related]  

  • 22. [Synthesis and spectral properties of substituted guanamines suitable for chromatography of biguanides].
    Bellenger P; Hamon M; Mahuzier G
    Ann Pharm Fr; 1983; 41(4):327-37. PubMed ID: 6670817
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on the metabolism of ketone bodies and pyruvic acid in patients with various endocrine disorders. 3. Effects of sulfonylureas, biguanides and insulin on the concentration of blood ketone bodies and pyruvate in diabetics].
    Morikami S
    Naika Hokan; 1966 Oct; 13(10):445-53. PubMed ID: 6009579
    [No Abstract]   [Full Text] [Related]  

  • 24. [Ion-exchange thin-layer chromatography of nucleotides. II. Fractionation with elution gradient].
    Schettino O; La Rotonda MI
    Boll Soc Ital Biol Sper; 1968 Dec; 44(23):1989-91. PubMed ID: 5735762
    [No Abstract]   [Full Text] [Related]  

  • 25. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
    Goo AK; Carson DS; Bjelajac A
    J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Search for potent hypoglycaemic agents. II. Mode of action of synthetic hypoglycaemic agents (biguanides).
    PAUL SP; BOSE AN
    Indian J Physiol Pharmacol; 1962 Jan; 6():38-46. PubMed ID: 14484489
    [No Abstract]   [Full Text] [Related]  

  • 27. [Separation and identifying features of the cardiac aglycones and glycosides of Nerium oleander L. flowers by thin-layer chromatography].
    Boisio ML; Esposito M; Merlo F
    Minerva Med; 1993 Nov; 84(11):627-32. PubMed ID: 8015691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.
    Harrigan RA; Nathan MS; Beattie P
    Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative liquid chromatography of sulfonylureas in pharmaceutical products.
    Beyer WF
    Anal Chem; 1972 Jun; 44(7):1312-4. PubMed ID: 4658154
    [No Abstract]   [Full Text] [Related]  

  • 30. Drugs and their abuse. II. Oral hypoglycaemic agents.
    Drury MI
    J Ir Med Assoc; 1971 May; 64(412):253-4. PubMed ID: 5579601
    [No Abstract]   [Full Text] [Related]  

  • 31. [Lactic acidosis associated with biguanides].
    Safadi R; Yossepowitch O; Ben-Yehuda A
    Harefuah; 1996 Feb; 130(4):280-3. PubMed ID: 8675126
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of diabetes mellitus with biguanides. Clinical studies on 524 patients].
    Klein W; Hole P; Dietzmann HB; Buding A
    Munch Med Wochenschr; 1969 Jun; 111(24):1363-6. PubMed ID: 5819845
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the mechanism of action of phenethylbiguanide (PEBG). 3. Effects on glucagon-induced hyperglycemia in vivo].
    Fratino P; Maggi G; Rodari T
    Boll Soc Ital Biol Sper; 1967 Dec; 43(24):1883-6. PubMed ID: 5601973
    [No Abstract]   [Full Text] [Related]  

  • 34. Emergency management of oral hypoglycemic drug toxicity.
    Rowden AK; Fasano CJ
    Emerg Med Clin North Am; 2007 May; 25(2):347-56; abstract viii. PubMed ID: 17482024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drug therapy of type-II diabetes: tablets, insulin or a combination of these].
    Diem P
    Schweiz Rundsch Med Prax; 1994 Jan; 83(3):68-71. PubMed ID: 8296132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [On the mechanism of action of phenethylbiguanide (PEBG). IV. Effect on adrenalin-induced hyperglycemia in normal animals].
    Fratino P; Maggi G; Rodari T
    Boll Soc Ital Biol Sper; 1967 Dec; 43(24):1886-8. PubMed ID: 5601974
    [No Abstract]   [Full Text] [Related]  

  • 37. [Study of the mode of action of the biguanides].
    POMETTA D; PLATTNER HC
    Helv Med Acta; 1963 Jun; 30():72-89. PubMed ID: 13972082
    [No Abstract]   [Full Text] [Related]  

  • 38. [Studies on the clinical application of biguanides].
    Takamura Y; Kobayashi Y; Sasaki S; Fukushima K
    Naika; 1968 Dec; 22(6):1365-70. PubMed ID: 5719274
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antidiabetic biguanides and lactic acidosis].
    Rojas Hidalgo E
    Rev Clin Esp; 1997 Aug; 197(8):568-73. PubMed ID: 9312795
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical pharmacology of oral hypoglycemic drugs].
    TatoĊ„ J
    Pol Tyg Lek; 1968 Sep; 23(34):1289-92. PubMed ID: 5722532
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.